Screen2Prevent (S2P)
for HIV Infections
Sites in Houston +4 more locations
Sponsor: Westat
Sex: All·Age: 14 - 24·Accepts healthy volunteers
Code: NCT07728123·Recruiting·Listed Jul 27, 2026
Clinical Trials at Baylor College of Medicine
As of August 2026, 175 paid clinical trials are recruiting at Baylor College of Medicine, located at 1 BAYLOR PLZ, BCM 286, N1319, HOUSTON, TX 77030-3411, phone (713) 798-8918 in Houston, Texas. Active studies at this site cover conditions such as Breast Cancer, Acute Myeloid Leukemia and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Filter results
Newly added in Houston
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
GelPOINT® Path-Assisted Endoscopic Removal of Colon and Rectal Polyps: A Feasibility and Safety Study
for Polyp Colorectal
1 location in Houston
Sponsor: Baylor College of Medicine
Sex: All·Age: 18+
Code: NCT07723937·Recruiting·Listed Jul 23, 2026
NON-INVASIVE BRAIN STIMULATION FOR MEMORY LOSS IN EARLY ALZHEIMER'S DISEASE
for Alzheimer s Disease
1 location in Houston
Sponsor: Chi-Ying (Roy) Lin
Sex: All·Age: 55 - 90
Code: NCT07667478·Recruiting·Listed Jun 25, 2026
178 clinical trials at Baylor College of Medicine
·Clear filters·An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
for Cardiovascular Disease and Lipoprotein(a)
Drug: Pelacarsen
Sites in Houston, Tomball +110 more locations
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18 - 100
Code: NCT07517263·Phase 3·Recruiting·Listed Apr 2026
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
for Parkinson's Disease
Sites in Houston +25 more locations
Sponsor: Bayer
Sex: All·Age: 45 - 75
Code: NCT07330258·Recruiting·Listed Jan 2026
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for Clostridioides Difficile Associated Disease
Sites in Houston, Tomball +133 more locations
Sponsor: Pfizer
Sex: All·Age: 65+·Accepts healthy volunteers
Code: NCT07282665·Phase 3·Recruiting·Listed Dec 2025
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
for Cardiovascular Disease
Drug: Olpasiran
Sites in Houston, Humble +197 more locations
Sponsor: Amgen
Sex: All·Age: 50 - 105
Code: NCT07136012·Phase 3·Recruiting·Listed Aug 2025
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Sites in Houston, Bellaire +64 more locations
Sponsor: Sanofi
Sex: All·Age: 40 - 80
Code: NCT07190209·Phase 3·Recruiting·Listed Sep 2025
Assessment of CCM in HF With Higher Ejection Fraction
for Heart Failure
Sites in Houston, Round Rock +74 more locations
Sponsor: Impulse Dynamics
Sex: All·Age: 18+
Code: NCT05064709·Recruiting·Listed Oct 2021
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
for Depressive Disorder, Major
Drug: Seltorexant
Sites in Houston, Bellaire +40 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18 - 74
Code: NCT06559306·Phase 3·Recruiting·Listed Aug 2024
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
for Parkinson Disease
Sites in Houston, Round Rock +43 more locations
Sponsor: Neuron23 Inc.
Sex: All·Age: 40 - 80
Code: NCT06680830·Phase 2·Recruiting·Listed Nov 2024
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for Colorectal Cancer
Sites in Houston, Webster +30 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT06562543·Phase 4·Recruiting·Listed Aug 2024
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for Moderately to Severely Active Crohns Disease
Drug: Afimkibart
Sites in Houston, Temple +90 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 16 - 80
Code: NCT06819878·Phase 3·Recruiting·Listed Feb 2025
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
Sites in Houston, Baytown +44 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 75
Code: NCT06598943·Phase 2·Recruiting·Listed Sep 2024
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
for Peripheral Vascular Diseases
Sites in Houston, Austin +36 more locations
Sponsor: Boston Scientific Corporation
Sex: All·Age: 18+
Code: NCT04674969·Recruiting·Listed Dec 2020
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
for Chronic Obstructive Pulmonary Disease
Sites in Houston, Corsicana +61 more locations
Sponsor: Hoffmann-La Roche
Sex: All·Age: 40 - 90
Code: NCT05878769·Phase 3·Recruiting·Listed May 2023
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
for Colorectal Cancer
Sites in Houston, Irving +30 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06445062·Phase 1, Phase 2·Recruiting·Listed Jun 2024
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
for Progressive Pulmonary Fibrosis
Sites in Houston, El Paso +24 more locations
Sponsor: Avalyn Pharma Inc.
Sex: All·Age: 18+
Code: NCT06951217·Phase 2·Recruiting·Listed Apr 2025
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for Type 1 Diabetes Mellitus
Sites in Houston +31 more locations
Sponsor: Sanofi
Sex: All·Age: 1 - 25
Code: NCT07088068·Phase 3·Recruiting·Listed Jul 2025
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
for Eosinophilic Esophagitis (EoE)
Sites in Houston +28 more locations
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 1+
Code: NCT06693531·Recruiting·Listed Nov 2024
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
for Low-grade NMIBC
Sites in Houston, Austin +33 more locations
Sponsor: Tyra Biosciences, Inc
Sex: All·Age: 18+
Code: NCT06995677·Phase 2·Recruiting·Listed May 2025
A Study to Assess Growth in Children With Idiopathic Short Stature
for Idiopathic Short Stature
Sites in Houston +29 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 2 - 16
Code: NCT06309979·Recruiting·Listed Mar 2024
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
for Metastatic Breast Cancer
Sites in Houston +30 more locations
Sponsor: LeonaBio
Sex: All·Age: 18+
Code: NCT05696626·Phase 3·Recruiting·Listed Jan 2023
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for Platinum-resistant Ovarian Cancer
Drug: Bevacizumab
Sites in Houston +31 more locations
Sponsor: Genelux Corporation
Sex: Female·Age: 18+
Code: NCT05281471·Phase 3·Recruiting·Listed Mar 2022
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Sites in Houston +22 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
for Pulmonary Hypertension
Sites in Houston, Dallas +30 more locations
Sponsor: Tempus AI
Sex: All·Age: 18+
Code: NCT06911632·Recruiting·Listed Apr 2025
A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction
for Lung Transplant Rejection
Sites in Houston, San Antonio +30 more locations
Sponsor: Sanofi
Sex: All·Age: 18+
Code: NCT06082037·Phase 3·Recruiting·Listed Oct 2023
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
for Primary Biliary Cholangitis
Sites in Houston, Dallas +28 more locations
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT05050136·Phase 2·Recruiting·Listed Sep 2021
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
for Graft-versus-host Disease (GVHD)
Drug: Ruxolitinib
Sites in Houston +29 more locations
Sponsor: Incyte Corporation
Sex: All·Age: 18+
Code: NCT06615050·Phase 3·Recruiting·Listed Sep 2024
The PREDICT Registry:
for DCIS
Sites in Houston, Dallas +28 more locations
Sponsor: PreludeDx
Sex: Female·Age: 30 - 85
Code: NCT03448926·Recruiting·Listed Feb 2018
SELUTION4BTK Trial
for Peripheral Arterial Disease
Sites in Houston, Tyler +23 more locations
Sponsor: M.A. Med Alliance S.A.
Sex: All·Age: 18+
Code: NCT05055297·Recruiting·Listed Sep 2021
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Sites in Houston, Dallas +35 more locations
Sponsor: Intellia Therapeutics
Sex: All·Age: 18 - 90
Code: NCT06128629·Phase 3·Recruiting·Listed Nov 2023
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
for Agitation
Sites in Houston, Beaumont +25 more locations
Sponsor: Suven Life Sciences Limited
Sex: All·Age: 50 - 90
Code: NCT05397639·Phase 3·Recruiting·Listed May 2022
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
for Idiopathic Short Stature
Drug: Vosoritide
Sites in Houston, Dallas +29 more locations
Sponsor: BioMarin Pharmaceutical
Sex: All·Age: 3 - 11
Code: NCT06382155·Phase 2·Recruiting·Listed Apr 2024
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
for Type 2 Diabetes Mellitus
Sites in Houston +10 more locations
Sponsor: Insulet Corporation
Sex: All·Age: 14 - 75
Code: NCT07579702·Recruiting·Listed May 2026
A Study of TAK-505 in Adults With Solid Tumors
for Malignant Solid Tumors
Drug: TAK-505
Sites in Houston, San Antonio +13 more locations
Sponsor: Takeda
Sex: All·Age: 18+
Code: NCT07436728·Phase 1, Phase 2·Recruiting·Listed Feb 2026
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
for Major Depressive Disorder (MDD)
Sites in Houston, Katy +20 more locations
Sponsor: ACADIA Pharmaceuticals Inc.
Sex: All·Age: 18 - 65
Code: NCT07284667·Phase 2·Recruiting·Listed Dec 2025
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for Lymphoma, Non-Hodgkin's
Drug: LY4584180
Sites in Houston, Dallas +19 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07226843·Phase 1·Recruiting·Listed Nov 2025
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
for Type 1 Diabetes Mellitus
Sites in Houston +9 more locations
Sponsor: Mannkind Corporation
Sex: All·Age: 10 - 17
Code: NCT07224321·Phase 2·Recruiting·Listed Nov 2025
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for Ovarian Neoplasms
Sites in Houston, Dallas +17 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07213791·Phase 1·Recruiting·Listed Oct 2025
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
for Symptomatic Genetic Dilated Cardiomyopathy
Sites in Houston +27 more locations
Sponsor: Kardigan, Inc.
Sex: All·Age: 18+
Code: NCT07210723·Phase 2, Phase 3·Recruiting·Listed Oct 2025
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
for Familial Pulmonary Fibrosis
Drug: Nerandomilast
Sites in Houston +12 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 40+
Code: NCT07201922·Phase 3·Recruiting·Listed Oct 2025
A Study of BLB-201 RSV Vaccine in Infants and Children
for Respiratory Syncytial Virus Infections
Sites in Houston, Cedar Park +14 more locations
Sponsor: Blue Lake Biotechnology Inc.
Sex: All·Age: 6 Months - 5·Accepts healthy volunteers
Code: NCT05655182·Phase 1, Phase 2·Recruiting·Listed Dec 2022
Common conditions studied in Houston
- Breast Cancer (79 active studies)
- Acute Myeloid Leukemia (54 active studies)
- Advanced Solid Tumor (53 active studies)
- Ovarian Cancer (47 active studies)
- Colorectal Cancer (45 active studies)
- Prostate Cancer (43 active studies)
Leading research sponsors in Houston
- M.D. Anderson Cancer Center
- The University of Texas Health Science Center, Houston
- Baylor College of Medicine
- AstraZeneca
- The Methodist Hospital Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Houston?
There are approximately 3,038 recruiting clinical trials in Houston, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Houston pay participants?
Most recruiting trials in Houston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Houston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Houston?
The most common conditions under active study in Houston include Breast Cancer (79), Acute Myeloid Leukemia (54), Advanced Solid Tumor (53), Ovarian Cancer (47), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Houston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Houston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Houston?
Recruiting research sites in Houston include MD Anderson Cancer Center, M D Anderson Cancer Center, Baylor College of Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Houston right now?
The largest active categories in Houston are Cancer & tumors (1,191), Neurology & pain (145), Diabetes & metabolic (103). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Baylor College of Medicine?
Baylor College of Medicine is located at 1 BAYLOR PLZ, BCM 286, N1319, HOUSTON, TX 77030-3411. Use the Google Maps link in the intro above to get directions.
How do I contact Baylor College of Medicine?
You can reach Baylor College of Medicine by phone at (713) 798-8918. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.
Browse more clinical trials
Other cities in Texas
Dallas, TX(1,543)San Antonio, TX(986)Austin, TX(682)Fort Worth, TX(327)El Paso, TX(180)Plano, TX(167)Tyler, TX(153)Sugar Land, TX(127)Irving, TX(117)The Woodlands, TX(113)Lubbock, TX(104)Bellaire, TX(98)Galveston, TX(85)Amarillo, TX(83)Richardson, TX(78)McAllen, TX(73)McKinney, TX(69)Temple, TX(69)Arlington, TX(64)Corpus Christi, TX(60)Webster, TX(60)DeSoto, TX(58)Mesquite, TX(57)Katy, TX(54)Waco, TX(52)Abilene, TX(48)Round Rock, TX(47)Tomball, TX(47)Beaumont, TX(44)Kingwood, TX(42)Conroe, TX(41)Edinburg, TX(40)League City, TX(40)Southlake, TX(40)Baytown, TX(39)Cypress, TX(38)Denton, TX(37)Lewisville, TX(37)Mansfield, TX(33)Allen, TX(31)Denison, TX(31)Frisco, TX(31)Harlingen, TX(31)Humble, TX(28)Brownsville, TX(27)Shavano Park, TX(26)Wichita Falls, TX(26)Weslaco, TX(25)Georgetown, TX(24)Richmond, TX(24)Carrollton, TX(22)Sherman, TX(22)College Station, TX(21)Flower Mound, TX(21)Fort Sam Houston, TX(21)Longview, TX(20)Bedford, TX(18)Garland, TX(18)Pearland, TX(18)Cedar Park, TX(17)